Compare PKOH & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PKOH | PACB |
|---|---|---|
| Founded | 1907 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 553.5M | 521.8M |
| IPO Year | 1994 | 2010 |
| Metric | PKOH | PACB |
|---|---|---|
| Price | $39.10 | $1.36 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 1 | 3 |
| Target Price | ★ $37.00 | $1.67 |
| AVG Volume (30 Days) | 65.2K | ★ 5.9M |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.69% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.57 | N/A |
| Revenue | ★ $1,599,100,000.00 | $93,468,000.00 |
| Revenue This Year | $7.87 | $11.32 |
| Revenue Next Year | $3.42 | $12.14 |
| P/E Ratio | $67.49 | ★ N/A |
| Revenue Growth | N/A | ★ 3.04 |
| 52 Week Low | $15.52 | $1.09 |
| 52 Week High | $39.69 | $2.73 |
| Indicator | PKOH | PACB |
|---|---|---|
| Relative Strength Index (RSI) | 57.78 | 41.92 |
| Support Level | $33.76 | $1.27 |
| Resistance Level | $39.33 | $1.79 |
| Average True Range (ATR) | 1.58 | 0.09 |
| MACD | -0.05 | -0.02 |
| Stochastic Oscillator | 69.03 | 11.11 |
Park-Ohio Holdings Corp is a diversified international company offering its clients supply chain management outsourcing services, capital equipment used on their production lines, and manufactured components used to assemble their products. The company operates through three reportable segments: Supply Technologies, Assembly Components, and Engineered Products. Maximum revenue is generated from the Supply Technologies segment, which is mainly engaged in sourcing, planning, and procurement of several production components, including fasteners, pins, nuts, bolts, valves, hoses, wire harnesses, clamps and fittings, etc. Geographically, the company generates maximum revenue from its business in the United States, followed by Europe, Asia, Mexico, Canada, and other regions.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.